This generic ICR
is approved consistent with AHRQ agreement to submit individual
information colletions to OMB as they are implemented, along with
all necessary supporting statements. Furthermore, this generic ICR
is approved on the understanding that: 1) AHRQ does not intend to
use data derived from this clearance in analytic publications of
any sort; 2) the intent of testing of materials already in
circulation would be only to improve future products and would not
in any way be an evaluation. The scope and intent of such
activities would clearly be specified in the supporting statements
associated with the specific collection; 3) OMB will aim to review
each IC submission within 14 days; however, OMB approval should not
be assumed if not explicitly granted, even if 14 days have elapsed
since submission.
Inventory as of this Action
Requested
Previously Approved
02/28/2010
36 Months From Approved
1,320
0
0
1,016
0
0
0
0
0
AHRQ's newly-established Eisenberg
Center is an innovative effort aimed at improving communication of
findings to a variety of audiences ("customers"), including
consumers, clinicians, payers, and health care policy makers. The
Eisenberg Center, one of three components of AHRQ's Effective
Health Care Program announced in September 2005, is directed
through a contract by the Oregon Health and Science University,
Department of Medicine, located in Portland, Oregon. The Eisenberg
Center intends to employ the latest survey research techniques to
(1) determine how well its products and services are meeting
customers' current and anticipated needs; (2) identify problem
areas with existing products and services and determine what
improvements should be made to improve these products and services;
and (3) identify and develop new products and services. To address
customer requirements and to evaluate current and future AHRQ
products and services, the Eisenberg Center must periodically
determine how well the Eisenberg Center products and services are
meeting customers' current and anticipated needs. Work conducted
under this clearance will improve the products and services the
Center develops for AHRQ for a three year period. The health care
environment changes rapidly and requires a quick response from AHRQ
to provide appropriately refined products and services. A generic
clearance for this work will facilitate AHRQ's timely response to
customers' needs.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.